Market News / Story
Novavax, Inc. Stock 12‑Month Price Target Raised to $14.86, Implies 35% Upside
·
According to estimates from 7 analysts, Novavax, Inc. stock's average price target has risen from $14.71 to $14.86, with forecasts ranging from $7 to $25 per share Based on the Oct. 8 closing price, the updated target implies approximately 35% potential upside Consensus rating has shifted to “Buy” across 7 covering analysts, with 4 Buys, 1 Holds and 2 Sells Explore more price target data and ratings for Novavax, Inc. on the Forecasts tab , and track all previous and…